ConductScience.org, home

Paper366756

Assessment of response and recurrence in breast cancer.

Hayward JL and 2 others. Semin Oncol, 1978. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Assessment of response and recurrence in breast cancer. Papers, record 366756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/366756

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessment of response and recurrence in breast cancer.
PubMed
Journal
Semin Oncol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2007-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hayward JLJ L
2Meakin JWJ W
3Stewart HJH J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Clinical Trials as Topic
Female
Humans
Recurrence
Research Design
Therapeutics
Time Factors

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
20859353Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study.J Oncol Pract2006https://conductscience.org/library/papers/20859353PubMed
12065263Stressful life experiences and risk of relapse of breast cancer: observational cohort study.BMJ2002https://conductscience.org/library/papers/12065263PubMed
10098755A high incidence of vertebral fracture in women with breast cancer.Br J Cancer1999https://conductscience.org/library/papers/10098755PubMed
8912543Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.Br J Cancer1996https://conductscience.org/library/papers/8912543PubMed
3697513Response to endocrine therapy and breast cancer differentiation.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3697513PubMed
2849974An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.Br J Cancer1988https://conductscience.org/library/papers/2849974PubMed
2493899Stress and relapse of breast cancer.BMJ1989https://conductscience.org/library/papers/2493899PubMed
1873550Recurrence and survival rates in British and Japanese women with breast cancer.Breast Cancer Res Treat1991https://conductscience.org/library/papers/1873550PubMed
1873549Patterns of recurrence and relapse--Anglo-Japanese comparative study.Breast Cancer Res Treat1991https://conductscience.org/library/papers/1873549PubMed
1764379Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre.Br J Cancer1991https://conductscience.org/library/papers/1764379PubMed
1391992A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer.Breast Cancer Res Treat1992https://conductscience.org/library/papers/1391992PubMed
1333787Expression of the ERBB3 gene product in breast cancer.Br J Cancer1992https://conductscience.org/library/papers/1333787PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/366756

GET https://conductscience.org/api/papers/v1/366756/authors